VRNA Bathi mangsa ngarep Verona Pharma PLC

Simbol resmi perusahaan Verona Pharma PLC (VRNA)

Verona Pharma plc (VRNA) is implementing advanced therapy methods for severe pulmonary pathologies, creating unique classes of medications. Business growth relies on partnerships with global industry behemoths to ensure the rapid launch of products. The current profit figure stands at 0.03, and the price action shown below highlights the risks associated with the approval of new drugs and the efficiency of their subsequent distribution.

veronapharma.com (VRNA): Bathi resik sing dikarepake saka 13.01.2025 nganti 18.10.2025

Verona Pharma Corp - rincian analitis lan metrik utama (VRNA)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:VRNA, Verona Pharma
Produk dadi Verona Pharma PLC

The commercial launch of the innovative drug Ohtuvayre for the treatment of COPD transitions Verona Pharma plc (VRNA) into a phase of active revenue scaling. The estimated profit dynamics reflect a daily revaluation of expected earnings based on a mathematical balance of risks, allowing investors to identify hidden drawdowns in the business's margin of safety that may be masked by one-off trades from major players during exchange sessions.

Analisis pesaing Verona Pharma plc

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep MENS (Jyong Biotech Corp)|LGND (Ligand Corp) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Amneal Pharmaceuticals, Inc. AMRX|Perrigo (PRGO) - Bathi resik sing dikarepake|ALVO: Bathi mangsa ngarep|Liquidia - Bathi resik mangsa ngarep|GLPG: Proyeksi bathi mangsa ngarep|ANI Pharma - Penghasilan resik sing dikarepake|MNKD (MannKind Corp) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake amphastar.com AMPH|Bathi sing dikarepake Pacira BioSciences, Inc. (PCRX)|SPRY (ARS Pharmaceuticals, Inc.) - Penghasilan resik sing dikarepake|Theravance Biopharma, Inc. - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep Aquestive Corp AQST|scPharmaceuticals - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake tectonictx.com|Tonix Pharmaceuticals Inc. (TNXP) - Bathi sing dikarepake|SXTC - Prakiraan bathi perusahaan|Bathi sing dikarepake eupraxiapharma.com|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan